Sumatriptan Nasal Spray for Acute Migraine

Sumatriptan Nasal Spray for Acute Migraine

Show other versions (1)

A multicenter, randomized, double-blind, placebo-controlled trial of sumatriptan nasal spray (5 mg, 10 mg, and 20 mg) was conducted in 653 adolescents presenting with acute migraine at the Palm Beach Headache Center, Florida; Cleveland Clinic, OH; Michigan Headache Institute, Ann Arbor; and San Anto...

Full description

Bibliographic Details
Main Author: J Gordon Millichap
Format: Article
Language:English
Published: Pediatric Neurology Briefs Publishers 2000-11-01
Series:Pediatric Neurology Briefs
Subjects:
higher efficacy rates
photophobia
headache recurrence
Online Access:https://www.pediatricneurologybriefs.com/articles/1841
id doaj-3d22d6136d8f4cc58efbf0ed8abe799c
record_format Article
spelling doaj-3d22d6136d8f4cc58efbf0ed8abe799c2020-11-24T21:47:15ZengPediatric Neurology Briefs PublishersPediatric Neurology Briefs1043-31552166-64822000-11-011411828310.15844/pedneurbriefs-14-11-31828Sumatriptan Nasal Spray for Acute MigraineJ Gordon Millichap0Northwestern University Feinberg School of MedicineA multicenter, randomized, double-blind, placebo-controlled trial of sumatriptan nasal spray (5 mg, 10 mg, and 20 mg) was conducted in 653 adolescents presenting with acute migraine at the Palm Beach Headache Center, Florida; Cleveland Clinic, OH; Michigan Headache Institute, Ann Arbor; and San Antonio Center, TX.https://www.pediatricneurologybriefs.com/articles/1841higher efficacy ratesphotophobiaheadache recurrence
collection DOAJ
language English
format Article
sources DOAJ
author J Gordon Millichap
spellingShingle J Gordon Millichap
Sumatriptan Nasal Spray for Acute Migraine
Pediatric Neurology Briefs
higher efficacy rates
photophobia
headache recurrence
author_facet J Gordon Millichap
author_sort J Gordon Millichap
title Sumatriptan Nasal Spray for Acute Migraine
title_short Sumatriptan Nasal Spray for Acute Migraine
title_full Sumatriptan Nasal Spray for Acute Migraine
title_fullStr Sumatriptan Nasal Spray for Acute Migraine
title_full_unstemmed Sumatriptan Nasal Spray for Acute Migraine
title_sort sumatriptan nasal spray for acute migraine
publisher Pediatric Neurology Briefs Publishers
series Pediatric Neurology Briefs
issn 1043-3155
2166-6482
publishDate 2000-11-01
description A multicenter, randomized, double-blind, placebo-controlled trial of sumatriptan nasal spray (5 mg, 10 mg, and 20 mg) was conducted in 653 adolescents presenting with acute migraine at the Palm Beach Headache Center, Florida; Cleveland Clinic, OH; Michigan Headache Institute, Ann Arbor; and San Antonio Center, TX.
topic higher efficacy rates
photophobia
headache recurrence
url https://www.pediatricneurologybriefs.com/articles/1841
work_keys_str_mv AT jgordonmillichap sumatriptannasalsprayforacutemigraine
_version_ 1725898357288730624

Similar Items